Search results for "Cardiovascular events"
Evidence evolving on aspirin as prevention
Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
https://immattersacp.org/archives/2019/03/evidence-evolving-on-aspirin-as-prevention.htm
1 Mar 2019
Demystifying the diagnosis of PCOS
Polycystic ovary syndrome, the most common reproductive disorder in the world, may present with varying diagnostic criteria, so internists can focus on two simple characteristics of the syndrome to help their clinical judgment.
https://immattersacp.org/archives/2018/11/demystifying-the-diagnosis-of-pcos.htm
1 Nov 2018
EpiPen expiration date extended, first generic approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/10/epipen-expiration-date-extended-first-generic-approved.htm
1 Oct 2018
Low-dose aspirin's effects on survival may come with caveats
A trial was stopped early after researchers determined that continued aspirin use appeared to yield no benefit.
https://immattersacp.org/weekly/archives/2018/09/18/2.htm
18 Sep 2018
Combat cardiac risks of cancer therapies
One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
https://immattersacp.org/archives/2018/09/combat-cardiac-risks-of-cancer-therapies.htm
1 Sep 2018
Higher omega-3 intake has little or no effect on mortality or cardiovascular events, review finds
Moderate- to high-quality evidence suggested little or no effect of increasing fish-based omega-3 fatty acids, while low- to moderate-quality evidence suggested that increasing plant-based omega-3s slightly reduces risk of cardiovascular events, risk of coronary heart disease mortality, and risk of arrhythmia.
https://immattersacp.org/weekly/archives/2018/07/24/1.htm
24 Jul 2018
Low-dose aspirin for primary prevention of CV events may only be effective in smaller people
The ability of 75 to 100 mg of aspirin to reduce cardiovascular events decreased with increasing weight, while doses of 325 mg or more had the opposite interaction with body weight, reducing cardiovascular events only in people who weighed more.
https://immattersacp.org/weekly/archives/2018/07/24/2.htm
24 Jul 2018
Cardiovascular safety of febuxostat and allopurinol compared in patients with gout and CVD
In a modified intention-to-treat analysis, the primary end point of first occurrence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or urgent revascularization for unstable angina occurred in 10.8% of patients taking febuxostat and in 10.4% of patients taking allopurinol (hazard ratio, 1.03).
https://immattersacp.org/weekly/archives/2018/03/20/4.htm
20 Mar 2018
Migraine associated with cardiovascular risks
Higher absolute risks of cardiovascular disease were observed among patients with migraine across most outcomes and follow-up periods during 19 years of follow-up.
https://immattersacp.org/weekly/archives/2018/02/06/4.htm
6 Feb 2018
Calculate ‘sum of the parts' to pinpoint CV risk in women
Women face a steep increase in cardiovascular risk after menopause, requiring internists to incorporate composite indicators into the annual exam at midlife.
https://immattersacp.org/archives/2018/01/calculate-sum-of-the-parts-to-pinpoint-cv-risk-in-women.htm
1 Jan 2018